Metro Infectious Disease Consultants

Quick facts

Marketed products

• CCP · Infectious Disease
  CCP is a convalescent plasma product that provides passive immunotherapy through antibodies from recovered COVID-19 patients to treat active SARS-CoV-2 infection.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Metro Infectious Disease Consultants portfolio CI brief
• Metro Infectious Disease Consultants pipeline updates RSS